Enteric Disease Testing Market

Global Enteric Disease Testing Market Size

The global enteric disease testing market was valued at USD 2.50 billion in 2025, is estimated to reach USD 2.61 billion in 2026, and is projected to reach USD 3.65 billion by 2034, growing at a CAGR of 4.30% from 2026 to 2034.

The body may lose fluids and essential nutrients due to intestinal illnesses. Anorexia, nausea, vomiting, and stomach discomfort are common symptoms of enteric disorders. Enteric diseases, which include parasites, viruses, and bacteria, are brought on by foreign antigens. The most common infections causing intestinal diseases include Salmonella, Shigella, rotavirus, norovirus, E. coli, and Vibro Cholerae. The enteric disease mainly occurs through consuming contaminated food and can be transmitted from one infected person to another. The testing of enteric illnesses is generally carried out by using cultures and observing the samples of the patient's blood, bone marrow, tissue, etc., for any pathogen. It is essential to perform enteric disease testing to cure the diseases caused by these foreign invaders and exercise caution.

MARKET DRIVERS

The demand for early diagnosis of the enteric disease is anticipated to increase due to the increasing prevalence of enteric infections and the cost-effectiveness of technologically enhanced diagnostic equipment leading to a rise in the enteric disease testing market. A classic diagnostic method, like the culture method, required experienced personnel and was arduous and time-consuming. Therefore, Over the past ten years, the market for testing enteric disorders has undergone a revolution thanks to the advent of molecular diagnostics and other diagnostic technologies.

Increasing rates of death, especially in developing countries, push market growth. For example, 90% of deaths connected to diarrhea are also caused by a lack of access to safe drinking water and basic sanitary facilities. Additionally, 90% of typhoid-related mortality occurs in Asia. Furthermore, growing demand for early detection of various illnesses, increased gastrointestinal disease in developing countries, inadequate laboratory conditions, and shared knowledge are all leading to a spike in cases of enteric infection, pushing the need for a testing market.

Enteric disease testing is becoming increasingly important as people's preferences for convenience foods change, and they prefer packaged items with preservatives to increase the shelf life of packaged goods. However, these packages of goods can cause problems like food poisoning. Additionally, the post covid world is exceptionally cautious about food safety, and the government initiatives and key market players' investments towards improving healthcare facilities are expected to drive the market growth.

MARKET RESTRAINTS

Factors such as the rise in the incidence of undiscovered gastrointestinal illnesses and the lack of patient awareness in emerging countries, along with the high cost of labor and labor-intensive equipment, as well as the necessity for sophisticated laboratory conditions for clinical diagnoses, are primarily hampering the growth of the enteric disease testing market. In addition, the absence of reimbursement legislation in developing nations like China and India, along with the weak regulation of pathogen testing in emerging economies.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Pathogen Tested Insights

The E-coli segment is expected to lead the enteric disease testing market during the forecast period due to the prevalence of the diseases caused by e-coli infections. In addition, E-coli is the most prominent cause of enteric diseases, especially in children.

By Technology Insights

Based on technology, the rapid segment is anticipated to lead the market during the forecast period. Therefore, the rapid technology sector is also leading the market. This is because the food industry uses rapid technology to track the number, type, and metabolites of microorganisms that result in food spoilage, preservation, fermentation, safety, and foodborne pathogens.

By End-User Insights

Throughout the projected period, the market is anticipated to be dominated by the food category. Government and public health institutions now closely monitor food quality and move fast to identify, contain, and eradicate outbreaks' causes because of the growth of the food trade.

REGIONAL ANALYSIS

Geographically, the North American region is forecasted to showcase significant domination among all the regions in the global market during the forecast period owing to the high consumer awareness of nutritious meals and nutrition, rising typhoid prevalence, expensive goods, a crowded market, and a focus on identifying, monitoring, and preventing foodborne illnesses along with the prevalence of packages and canned food consumptions in the countries like the U.S. and Canada. On the other hand, the European market is also fast growing due to a sizable elderly population, substantial levels of technology adoption, supportive government measures, and collaborations and mergers amongst enterprises.

The market in Asia-Pacific and Latin America are expected to be the fastest growing due to the growing public knowledge of testing and infections, the population living in metropolitan areas with gastrointestinal disorders, biomedical research accelerating R&D in the detection and treatment of infectious diseases, and consumer demand for higher-quality healthcare services.

KEY MARKET PLAYERS

Some of the notable players in the global enteric disease testing market are

• DiaSorin
• bioMérieux
• Quest Diagnostics
• Meridian Bioscience
• Bio-Rad Laboratories
• BD
• Alere Inc.
• Cepheid
• Biomerica Inc.
• Coris BioConcept
• SGS S.A.
• Intertek Group Plc
• Bureau Veritas
• ALS Limited
• TÜV SÜD

MARKET SEGMENTATION

This research report on the global enteric disease testing market has been segmented and sub-segmented based on the pathogen, technology, end-user, and region.

By Pathogen Tested

• Campylobacter

• Listeria
• Salmonella
• E. Coli
• Other Pathogens (Clostridium; Hepatitis A, B, And E; Enterobacteriaceae, Shigella, Norovirus, Rotavirus, And Vibrio)

By Technology

• Rapid

• Convenience-Based
• Immunoassay
• Chromatography & Spectrometry
• Traditional
• Polymerase Chain Reaction (PCR)

By End-User

• Food

  • Meat, Poultry, And Seafood
  • Processed Food
  • Dairy Products
  • Fruits & Vegetables
  • Other Food Products (Includes Nuts, Herbs & Spices, And Cereals &Grain)
• Water

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa